對沖基金買入最多的股票
41.77k 個跟隨者 • 31 個股票代號 追蹤清單由 Yahoo Finance 提供
跟隨此名單即可探索和追蹤上一季對沖基金買入最多的股票。
策劃人： Yahoo Finance
跟隨此名單即可探索和追蹤上一季對沖基金買入最多的股票。
背景
雅虎財經運用先進的演算法持續觀察和探索全球金融市場的趨勢。我們會以觀察名單的形式向您提供深入分析。
透過雅虎財經篩選器尋找其他致勝投資意見。
這些股票如何加權？此觀察名單的股票比重相等。
表現
| 追蹤清單 | 今日股價變化 | 1 個月回報 | 1 年回報 | 總回報 |
|---|---|---|---|---|
| 對沖基金買入最多的股票 | +1.71% | - | - | - |
| ^GSPC | +1.11% | -0.43% | +20.31% | +5770.00% |
31 個股票代號
| 代號 | 公司名稱 | 收市價 | 變化 | % 變化 | 市場時間 | 成交量 | 平均成交量 (3 個月) | 市值 |
|---|---|---|---|---|---|---|---|---|
| BSX | Boston Scientific Corporation | 74.92 | +0.66 | +0.89% | 下午4:00 [EDT] | 7.59M | 5.92M | 110.15B |
| FCX | Freeport-McMoRan Inc. | 45 | +0.47 | +1.06% | 下午4:00 [EDT] | 10.39M | 13.32M | 64.64B |
| GEV | GE Vernova Inc. | 173.11 | +13.11 | +8.19% | 下午4:00 [EDT] | 3.44M | 3.28M | 47.57B |
| HES | Hess Corporation | 150.25 | +0.40 | +0.27% | 下午4:00 [EDT] | 1.16M | 2.13M | 46.29B |
| VST | Vistra Corp. | 71.12 | +0.74 | +1.05% | 下午4:00 [EDT] | 3.53M | 8.90M | 24.71B |
| BAX | Baxter International Inc. | 35.51 | +0.42 | +1.20% | 下午4:00 [EDT] | 3.47M | 4.85M | 18.10B |
| CNH | CNH Industrial N.V. | 10.4 | +0.16 | +1.56% | 下午4:00 [EDT] | 6.06M | 8.18M | 13.08B |
| EDU | New Oriental Education & Technology Group Inc. | 73.4 | +3.07 | +4.37% | 下午4:00 [EDT] | 2.56M | 1.55M | 12.15B |
| NOV | NOV Inc. | 19.85 | +1.18 | +6.32% | 下午4:00 [EDT] | 10.99M | 2.93M | 7.85B |
| BBWI | Bath & Body Works, Inc. | 34.17 | +1.04 | +3.14% | 下午4:00 [EDT] | 3.77M | 3.16M | 7.63B |
| RBRK | - | 34.71 | +0.29 | +0.84% | 下午4:00 [EDT] | 541.53k | 1.12M | 6.25B |
| SQSP | Squarespace, Inc. | 43.91 | - | - | 下午4:00 [EDT] | 792.77k | 1.27M | 6.03B |
| LOAR | Loar Holdings Inc. | 62.77 | +0.51 | +0.82% | 下午4:00 [EDT] | 353.14k | 329.51k | 5.63B |
| WRBY | Warby Parker Inc. | 16.52 | +0.29 | +1.79% | 下午4:00 [EDT] | 1.00M | 1.36M | 1.96B |
| ZUO | Zuora, Inc. | 9.48 | +0.23 | +2.49% | 下午4:00 [EDT] | 877.34k | 1.20M | 1.40B |
| OCUL | Ocular Therapeutix, Inc. | 8.43 | +0.15 | +1.81% | 下午4:00 [EDT] | 799.09k | 2.35M | 1.31B |
| URGN | UroGen Pharma Ltd. | 16.35 | -0.01 | -0.06% | 下午4:00 [EDT] | 306.13k | 647.53k | 673.13M |
| CWBC | Community West Bancshares | 20.2 | +0.05 | +0.25% | 下午4:00 [EDT] | 75.70k | 67.38k | 382.58M |
| DCTH | Delcath Systems, Inc. | 8.7 | - | - | 下午4:00 [EDT] | 163.83k | 265.82k | 241.74M |
| TRVI | Trevi Therapeutics, Inc. | 3.25 | +0.08 | +2.52% | 下午4:00 [EDT] | 144.67k | 230.70k | 228.91M |
| CYBN | Cybin Inc. | 0.2869 | +0.00 | +0.53% | 下午4:00 [EDT] | 2.16M | 4.29M | 217.96M |
| ABEO | Abeona Therapeutics Inc. | 5.1 | +0.07 | +1.39% | 下午4:00 [EDT] | 240.91k | 627.77k | 208.91M |
| MYO | Myomo, Inc. | 4.89 | +0.03 | +0.62% | 下午4:00 [EDT] | 280.69k | 444.85k | 140.90M |
| CNGL | Canna-Global Acquisition Corp | 10.96 | - | - | 下午4:00 [EDT] | 18.00 | 110.23k | 92.58M |
| GBBK | Global Blockchain Acquisition Corp. | 11.03 | - | - | 下午4:00 [EDT] | 8.52k | 4.79k | 87.55M |
| NSPR | InspireMD, Inc. | 3.39 | +0.41 | +13.76% | 下午4:00 [EDT] | 100.72k | 17.54k | 85.61M |
| CLRB | Cellectar Biosciences, Inc. | 2.29 | -0.08 | -3.17% | 下午4:00 [EDT] | 566.84k | 637.15k | 82.09M |
| EGRX | Eagle Pharmaceuticals, Inc. | 5.72 | -0.02 | -0.35% | 下午4:00 [EDT] | 33.76k | 178.08k | 74.12M |
| GLT | Glatfelter Corporation | 1.49 | - | - | 下午4:00 [EDT] | 130.26k | 378.24k | 67.43M |
| ET-PI | Energy Transfer LP | 11.455 | +0.06 | +0.49% | 下午3:43 [EDT] | 32.05k | 63.68k | - |
Insider MonkeyMyomo, Inc. (MYO): Hedge Funds Are Bullish on This Robotics Stock Now
We recently compiled a list of the 8 Best Robotics Stocks Under $10. In this article, we are going to take a look at where Myomo, Inc. (NYSE:MYO) stands against the other robotic stocks under $10. The concept of lifelike machines performing human tasks is fascinating to some and unsettling to others. However, robotics is […]
ZacksVistra Corp. (VST) Advances But Underperforms Market: Key Facts
Vistra Corp. (VST) closed the most recent trading day at $71.12, moving +1.05% from the previous trading session.
ZacksInteger Holdings (ITGR) Q2 Earnings Top Estimates, Margins Up
Integer Holdings' (ITGR) second-quarter results reflect robust Medical Sales, along with strength in all the product lines.
